GT Biopharma Inc. Common Stock
$7.81
-$1.19 (-13.22%)
$7.31Day Range$9.04
Key Statistics
Market Cap
$14.09M
Shares Outstanding
1.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Feb 11, 2021
Round Lot
100
Locale
US
Trading Data
Day Open
$9.04
Day High
$9.04
Day Low
$7.31
Volume
107.9K
VWAP
$7.95
Prev Close
$9.00
Transactions
--
Acc. Volume
--
About GT Biopharma Inc. Common Stock
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.
PHARMACEUTICAL PREPARATIONSSIC 28341 employees505 MONTGOMERY STREET, SAN FRANCISCO, CA, 94111(800) 304-9888IPO Feb 11, 2021US / STOCKSActiveWebsite
Identifiers
- CIK
- 0000109657
- Composite FIGI
- BBG000DHJ738
- Share Class FIGI
- BBG001S80Y31
- Ticker Root
- GTBP
- SIC Code
- 2834
About GT Biopharma Inc. Common Stock (GTBP) Stock
GT Biopharma Inc. Common Stock (GTBP) closed the 2026-09-16 session at $7.81, down 13.22% versus the previous close (-1.19). The stock opened at $9.04 and traded between $7.31 and $9.04 during that session. Session trading volume was 108K shares. The volume-weighted average price (VWAP) is $7.95.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.
GT Biopharma Inc. Common Stock has a market capitalization of $14.1 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. GTBP is listed on the XNAS exchange. The company employs approximately 1 people. GT Biopharma Inc. Common Stock is headquartered in SAN FRANCISCO, CA. The recorded listing date is 2021-02-11.
On this page you can find market GTBP stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.